CLAUDIA GALLENSTEIN: Open Payments
NPI 1710517867 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 62 payments from 29 companies in 2025. Trend: 2023 $19 · 2024 $711 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $319 |
| GENZYME CORPORATION | 1 | $125 |
| Merck Sharp & Dohme LLC | 4 | $103 |
| Genentech, Inc. | 1 | $102 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Daiichi Sankyo Inc. | 3 | $69 |
| BeOne Medicines USA, Inc. | 3 | $54 |
| Blueprint Medicines Corporation | 2 | $53 |
Products named: SARCLISA, IMFINZI, KEYTRUDA, Columvi, ERLEADA, OPDIVO, Enhertu, KISQALI.
Industry payments across AL — which companies pay providers there.
